Jim Cramer reacts to Unity stock market debut: ‘Patience is a virtue’

Jim Cramer reacts to Unity stock market debut: 'Patience is a virtue'

“Like all the other red-hot IPOs we’ve seen this week, you need to let Unity cool down before you even think about touching it,” the “Mad Money” host said. Hint: It’s a strategic move that relates to your Social Security benefits. Sep 18, 2020 (Market Insight Reports) —
Market Study Report, LLC, elucidates a comprehensive research of the ‘Electric Motors market’ that mentions valuable… 3D Printed Surgical Model Market Research Report by Specialty (Cardiac Surgery/ Interventional Cardiology, Gastroenterology Endoscopy of Esophageal, Neurosurgery, Orthopedic Surgery, and Reconstructive Surgery), by End User (Ambulatory Surgical Center, Clinic, and Hospital) – Global Forecast to 2025 – Cumulative Impact of COVID-19 Acute Coronary Syndrome Therapeutic Market Research Report by Type (Non-ST-elevation Myocardial Infarction, ST-elevation Myocardial Infarction, and Vial Unstable Angina), by Drug (Antihypertensive, Antithrombotic, and Statins), by Treatment, by Diagnosis, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19 Williams, age 77, is focused on seasonal patterns that consistently play out over time.

Unity Software began trading on public markets on Friday, and CNBC’s Jim Cramer advised investors to follow the same buying strategy he laid out for the debuts of other companies earlier this week.

“Unity’s following the same script as every other deal this week, from Snowflake to JFrog to Amwell: It’s a good company with a stock that’s way too expensive at these levels” for retail investors, the “Mad Money” host said.

“I think patience is a virtue.”

The video game software developer closed at $68.35 in its market debut after shares were priced at $52 — above its range of $44 and $48 — in an initial public offering, raising about $1.3 billion. The stock opened on the New York Stock Exchange at $75 and peaked before noon at $76.79.

Unity helps game developers produce content and is behind many hit mobile games on the Apple Store and Google Play. The platform is also used for interactive, real-time and 3D applications with end markets not limited to architecture, engineering, construction, media, entertainment and automotive.

Game makers such as Take-Two Interactive have their own in-house programs to develop content, and Epic Games is a privately held competitor in the space. Cramer likes Unity, though, for its position among mobile apps and smaller independent companies.

“Like all the other red-hot IPOs we’ve seen this week, you need to let Unity cool down before you even think about touching it,” said Cramer, who owns a stake in Take-Two as part of his charitable trust. “I’d consider this one enticing around $50 or maybe less.”

Unity projects its total addressable market to be $29 billion, primarily in gaming. The company’s growth rate slowed thus far this year, registering 39% in the first half of 2020 compared with 42% growth in 2019. That year Unity posted revenue of $541.8 million, up from $380.7 million in 2018. The firm also posted a steeper loss of $163.2 million, 24% more than it lost the year prior.

Cramer said the stock should be bought at more attractive levels, given that Unity lacks exponential revenue growth or earnings prowess to justify its price-to-sales multiple, which values a stock based on the underlying company’s revenue forecasts.

“If they can maintain the current growth rate and generate some positive earnings before interest and taxes, then I’d be willing to bless paying up for this one, but they’re not there yet,” Cramer said. “For now, I can’t get behind Unity at 24 times sales, or even 18 times sales, where it came public this morning.”

Disclosure: Cramer’s charitable trust owns shares of Take-Two Interactive.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com

Source: www.cnbc.com

Author: Tyler Clifford


Worried About a Stock Market Crash During Retirement? This 1 Move Could Help Ease Your Fears

Worried About a Stock Market Crash During Retirement? This 1 Move Could Help Ease Your Fears

It’s been a volatile year for investors, as stocks plunged into bear market territory in March and then tanked again in early September. And while volatility can be a nightmare for all investors, it can be especially worrisome to retirees — specifically, those who rely on their 401(k) and IRA investments to generate the income they need to cover their living expenses.

If you’re nearing retirement and are concerned that a future stock market crash or series of crashes might cause you financial difficulties as a senior, here’s one move worth making: Hold off on claiming your Social Security benefits.

What does delaying your Social Security filing have to do with protecting yourself from a stock market downturn? A lot, actually.

You’re entitled to your full monthly Social Security benefit based on your personal earnings history once you reach full retirement age. That age is either 66, 67, or somewhere in between, depending on your year of birth. You’re allowed to claim Social Security before full retirement age (starting at age 62) for a reduced benefit, or you can delay Social Security all the way up until age 70 and boost your benefits by 8% a year in the process. And to be clear, that boost will be permanent.

Here’s how that ties into the stock market. If you’re able to collect a higher monthly Social Security benefit throughout retirement, you’ll be less reliant on your retirement savings to stay afloat. Then, if the stock market does crash, a higher benefit may give you the option to either take much smaller withdrawals from your savings to avoid locking in major losses or, better yet, leave your savings alone completely and ride out those storms.

Imagine you’ll need $2,500 a month to cover your living costs as a senior, and you’re entitled to $1,600 a month in Social Security at a full retirement age of 67. If you delay your filing for three years, you’ll grow that benefit to $1,984. That means you’ll only need to withdraw $516 a month from savings, not $900.

Now, let’s say you go this route and the stock market crashes early on in retirement. You may, in that situation, be able to cut back on expenses so that you’re only removing $250 a month from your savings, thereby minimizing your investment losses. But without that Social Security boost, you’d likely be withdrawing — and losing — a lot more.

Of course, claiming Social Security at age 70 often means working until age 70, and that could be a mixed bag if you hate your job and can’t wait to escape it. On the flip side, if you push yourself to hold off on both Social Security and retirement until 70, you’ll also get an opportunity to boost your savings or, at the very least, leave your existing savings alone for longer. And that, too, could put you in a much stronger financial position throughout your senior years.

Source: www.fool.com

Author: Maurie Backman


Electric Motors Market with Report In Depth Industry Analysis on Trends, Growth, Opportunities and Forecast till 2026

Electric Motors Market with Report In Depth Industry Analysis on Trends, Growth, Opportunities and Forecast till 2026

Request a sample Report of Electric Motors Market at: https://www.marketstudyreport.com/request-a-sample/1695017?utm_source=Marketwatch&utm_medium=RV

The well-known companies profiled in the report include Emerson Electric Co., Rockwell Automation, Inc., Ametek, Inc., Siemens AG, Denso Corporation, Bosch Group, Baldor Electric Co., ABB Ltd., Hitachi, Ltd., General Electric Company, Allied Motion Technologies, Inc., and Regal Beloit Corporation among others. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Global Electric Motors market is anticipated to reach over USD 157.4 billion by 2026 according to a new study. In 2017, the AC motor segment dominated the global market, in terms of revenue Asia-Pacific is expected to be the leading contributor to the global market revenue of electric motors during the forecast period.

The growing adoption of electric vehicles is expected to support market growth of electric motors. The increasing requirement to reduce vehicle emissions and global carbon footprint drives the demand for electric vehicles. Use of electric vehicles offer benefits such as low maintenance costs, reduced harmful vehicle emissions, while providing comparable power. Electric vehicles are increasingly being used to restrict the emission of carbon, nitrogen, and other harmful compounds from gasoline and diesel vehicles. This is one of the largest ancillary industry which is pushing the demand for electric motors globally.

Enquiry about Electric Motors market report before Buying at: https://www.marketstudyreport.com/enquiry-before-buying/1695017?utm_source=Marketwatch&utm_medium=RV

Asia-Pacific generated the highest revenue in the market in 2017, and is expected to lead the global market throughout the forecast period. The presence of emerging industries such as healthcare, agriculture, construction, and automotive, substantial initiatives in research and development, and favorable government policies drive the market growth. Rapid industrialization and growth of manufacturing industry further support market growth in the region.

The different types of electric motors include AC motors, DC motors, and hermetic motors. In 2017, the AC motor segment accounted for the highest market share owing to the increasing demand for AC motors from industries such as agriculture, paper & pulp, and chemicals. They are majorly used in industrial applications and machine tools. Some key features offered by AC motors include controlled acceleration, low power demand on start, adjustable operational speed, adjustable torque limit, and reduced power line disturbances among others.

The diverse applications of electric motors in majority of industries such as healthcare, construction, packaging, automotive, and consumer goods among others are expected to support the growth of this market. Other driving factors include rising demand for electric motor in household appliances, growing use in HVAC applications, and government support for development of high efficiency electric motors are propelling the market growth. However, high maintenance costs, and stringent regulations hampering the market growth. Growing demand from emerging economies, and technological advancements are factors expected to provide numerous growth opportunities in the coming years.

Purchase full report of Electric Motors market at: https://www.marketstudyreport.com/securecheckout/paymenta/1695017?utm_source=Marketwatch&utm_medium=RV?msfpaycode=sumsf

Electric Motors Market share byMajor regions included:

United States
North America
Asia Pacific
Europe
Middle East & Africa

Table of Contents

1.Overview and Scope
1.1.Research goal & scope
1.2.Research assumptions
1.3.Research Methodology
1.3.1.Primary data sources
1.3.2.Secondary data sources
1.4.Key take-away
1.5.Stakeholders

2.Executive Summary
2.1.Market Definition
2.2.Market Segmentation
3.Electric Motors Market Insights
3.1.Electric Motors – Industry snapshot
3.2.Electric Motors – Ecosystem analysis
3.3.Electric Motors Market Dynamics
3.3.1.Electric Motors – Market Forces
3.3.1.1.Electric Motors Market Driver Analysis
3.3.1.2.Electric Motors Market Restraint/Challenges analysis
3.3.1.3.Electric Motors Market Opportunity Analysis
3.3.2.Industry analysis – Porter’s five force
3.3.2.1.Bargaining power of supplier
3.3.2.2.Bargaining power of buyer
3.3.2.3.Threat of substitute
3.3.2.4.Threat of new entrant
3.3.2.5.Degree of competition
3.3.3.Electric Motors Market PEST Analysis, 2017
3.3.4.Electric Motors Market Value Chain Analysis
3.3.5.Electric Motors Industry Trends
3.3.6.Competitive Ranking Analysis
4.Electric Motors Market Size and Forecast, 2017-2026 by Type
4.1.Key Findings
4.2.AC Motor
4.3.DC Motor
4.4.Hermetic Motors
5.Electric Motors Market Size and Forecast, 2017-2026 by Voltage
5.1.Key Findings
5.2.Upto 1kV
5.3.1kV – 6.6kV
5.4.Above 6.6kV

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report LLC

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email:sales@marketstudyreport.com

COMTEX_371506316/2599/2020-09-18T13:26:52

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Source: www.marketwatch.com


3D Printed Surgical Model Market Research Report by Specialty, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

3D Printed Surgical Model Market Research Report by Specialty, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19

New York, Sept. 18, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “3D Printed Surgical Model Market Research Report by Specialty, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19” – https://www.reportlinker.com/p05953102/?utm_source=GNW

The Global 3D Printed Surgical Model Market is expected to grow from USD 483.25 Million in 2019 to USD 983.17 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.56%.

Market Segmentation & Coverage:
This research report categorizes the 3D Printed Surgical Model to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Specialty, the 3D Printed Surgical Model Market studied across Cardiac Surgery/ Interventional Cardiology, Gastroenterology Endoscopy of Esophageal, Neurosurgery, Orthopedic Surgery, Reconstructive Surgery, Surgical Oncology, and Transplant Surgery. The Cardiac Surgery/ Interventional Cardiology further studied across Annuloplasty (Mitral Valve Repair), Repair Congenital Heart Defects, Repair Coronary Aneurysm, Replacement of Aortic Valve, and Stent Insertion. The Gastroenterology Endoscopy of Esophageal further studied across Endoscopy of Esophageal Lesion and Splenectomy. The Neurosurgery further studied across Remove Brain Tumor, Repair Aneurysm, and Transsphenoidal Excision of Pituitary Gland. The Orthopedic Surgery further studied across Hip Repair, Hip Replacement Revision, Osteotomy, Repair Clavicle Fracture, Repair Intervertebral Disc, Repair Leg Fracture, and Repair Scoliosis. The Reconstructive Surgery further studied across Breast Reconstruction, Cleft Palate Correction, Facial Reconstruction, Hand Reconstruction, and Mastoidectomy. The Surgical Oncology further studied across Endoscopic Removal of Cardiac Lesion, Removal of Adrenal Tumor, Removal of Liver Tumor, Removal of Renal Tumor, and Thoracic Removal of Lung Tumor. The Transplant Surgery further studied across Cardiac Surgery/ Interventional Cardiology, Heart Transplant, Kidney Transplant, Liver Transplant, and Lung Transplant.

Based on End User, the 3D Printed Surgical Model Market studied across Ambulatory Surgical Center, Clinic, and Hospital.

Based on Geography, the 3D Printed Surgical Model Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global 3D Printed Surgical Model Market including 3D LifePrints UK Ltd., 3D Systems, Inc., Axial3D, EnvisionTEC, Formlabs, GPI Prototype., Lazarus 3D, LLC, Materialise NV, Onkos Surgical, Osteo3D, Stratasys Ltd, and WhiteClouds Inc..

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the 3D Printed Surgical Model Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global 3D Printed Surgical Model Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global 3D Printed Surgical Model Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global 3D Printed Surgical Model Market?
4. What is the competitive strategic window for opportunities in the Global 3D Printed Surgical Model Market?
5. What are the technology trends and regulatory frameworks in the Global 3D Printed Surgical Model Market?
6. What are the modes and strategic moves considered suitable for entering the Global 3D Printed Surgical Model Market?
Read the full report: https://www.reportlinker.com/p05953102/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Source: www.globenewswire.com

Author: ReportLinker


Acute Coronary Syndrome Therapeutic Market Research Report by Type, by Drug, by Treatment, by Diagnosis, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

Acute Coronary Syndrome Therapeutic Market Research Report by Type, by Drug, by Treatment, by Diagnosis, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19

New York, Sept. 18, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Acute Coronary Syndrome Therapeutic Market Research Report by Type, by Drug, by Treatment, by Diagnosis, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19” – https://www.reportlinker.com/p05968807/?utm_source=GNW

The Global Acute Coronary Syndrome Therapeutic Market is expected to grow from USD 7,185.68 Million in 2019 to USD 10,257.45 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.11%.

Market Segmentation & Coverage:
This research report categorizes the Acute Coronary Syndrome Therapeutic to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Acute Coronary Syndrome Therapeutic Market studied across Non-ST-elevation Myocardial Infarction, ST-elevation Myocardial Infarction, and Vial Unstable Angina.

Based on Drug, the Acute Coronary Syndrome Therapeutic Market studied across Antihypertensive, Antithrombotic, and Statins.

Based on Treatment, the Acute Coronary Syndrome Therapeutic Market studied across Drug Treatment, Post Discharge Treatment, Prehospital Care, and Reperfusion Therapy. The Drug Treatment further studied across Antianginal Drug, Anticoagulant, and Antiplatelet Drug.

Based on Diagnosis, the Acute Coronary Syndrome Therapeutic Market studied across Blood Tests, Computerized Tomography Angiogram, Coronary Angiogram, Echocardiogram, and Imaging.

Based on End User, the Acute Coronary Syndrome Therapeutic Market studied across Academic Institutes, Diagnostic Centers, and Hospital & Clinics.

“The Asia-Pacific is projected to witness the highest growth during the forecast period”

Based on Geography, the Acute Coronary Syndrome Therapeutic Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Acute Coronary Syndrome Therapeutic Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Acute Coronary Syndrome Therapeutic Market including AbbVie Inc., Amgen Inc., AstraZeneca PLC, Baxter International Inc., Bayer AG, Beijing Minhai Biotechnology Co., Ltd., Biogen Inc., Boehringer Ingelheim International GmbH, Daiichi Sankyo Company, Limited., Eli Lilly and Company, Gilead Sciences, Inc.,, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc.,, Novartis International AG, Pfizer Inc., Portola Pharmaceuticals, Regeneron Pharmaceuticals, Inc., Resverlogix Corp., Sanofi S.A, Serum Institute of India, and Teva Pharmaceutical Industries Ltd..

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Acute Coronary Syndrome Therapeutic Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Acute Coronary Syndrome Therapeutic Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Acute Coronary Syndrome Therapeutic Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Acute Coronary Syndrome Therapeutic Market?
4. What is the competitive strategic window for opportunities in the Global Acute Coronary Syndrome Therapeutic Market?
5. What are the technology trends and regulatory frameworks in the Global Acute Coronary Syndrome Therapeutic Market?
6. What are the modes and strategic moves considered suitable for entering the Global Acute Coronary Syndrome Therapeutic Market?
Read the full report: https://www.reportlinker.com/p05968807/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Source: www.globenewswire.com

Author: ReportLinker


Stock market is at the start of a selloff, says veteran trader Larry Williams

Stock market is at the start of a selloff, says veteran trader Larry Williams

Attention, investors: Spooky times are on the way for the stock market.

Starting right about now, the stock market will see a significant and sustained selloff through about Oct. 10. Don’t look to gold as a hedge. It’s riding for a fall, too, despite the widespread misbelief that it protects you against losses in weak stock markets.

The bottom line: Ghosts and goblins come out in the market in the runup to Halloween, and we can expect the same this year.

That’s the view of trader Larry Williams, who offers weekly market insights at his website, I Really Trade. Why should you listen to Williams?

I’ve watched Williams accurately call many market twists and turns in the 15 years I’ve known him. I know of more than a few money managers who trust his judgement. Williams has won or placed well in the World Cup Trading Championship several times since the 1980s, and so have students and family members who apply his lessons.

He’s popular on the traders’ speaking circuit both in the U.S. and abroad. And Williams is regularly featured on Jim Cramer’s “Mad Money” show.

To make market calls, Williams uses his own time-tested mix of fundamentals, seasonal trends, technical signals and intelligence gleaned from the Commitment of Traders report from the Commodity Futures Trading Commission (CFTC). Here’s how he thinks about the three types of positions the CFTC reports. Williams considers positioning by commercial traders or hedgers and users and producers of commodities to be the smart money. He thinks large traders, mainly big investment shops, and the public are contrarian indicators.

Williams mainly trades futures because he thinks that’s where you can make the big money. But we can apply his calls to stocks and exchange traded funds, too. Here’s how he’s positioning for the next few weeks and through the end of the year, in some of the major asset classes and stocks.

To make market calls in September, Williams turns to what he calls the Machu Picchu trade, because he discovered this signal while traveling to the ancient Inca ruins with his wife in 2014. Williams, who is intensely focused on seasonal patterns that consistently play out over time, noticed that it’s usually a great idea to sell stocks — using indexes, mostly — on the seventh trading day before the end of September. (This year, that’s Sept. 22.) Selling on this day has netted profits in short-term trades 100% of the time over the past 22 years.

Williams also notes that selling on the 11th through the 20th trading day of September has been the right thing to do 80%-95% of the time, with one exception. Sales on the 17th trading day net gains 75% of the time — still not bad.

This year, that means the time for selling is Sept. 15-28. The percentage success rates cited above are for very short-term multi-day trades. But stocks tend to peak for the month in this time range, and then stay weak through around the middle of October. He thinks the pattern will repeat again this year.

“We’re most likely going to have a pullback in the market here,” says Williams.

One caveat: Watch the advance-decline line, one of Williams’ favorite indicators. If fewer stocks are declining relative to advancers on days the stock market is weak, or if there is a broadening out of participation on up days, this is a sign the any selloff may be coming to a close.

“If great breadth comes in to the market [on up days], then I will get bullish,” he says.

A lot of people think gold serves as a hedge during stock market declines, but this isn’t true, says Williams. Gold has slumped along with stocks in most of the major market selloffs. He expects the same over the next three to four weeks. He’s advising gold traders to sell any rallies now, and then revisit when gold falls later this year to buy back lower.

To make this call, Williams looks at the typical seasonal pattern for gold that plays out every year, and also the historical trends in election years. The conclusion: Gold typically peaks around the middle of September then weakens for most of the rest of the year. This year, gold has underperformed its typical seasonal pattern, which is bearish for the metal.

“Gold has not been able to stay in step with what happened in the past, therefore the seasonal pattern should work this year,” he says.

Another sign of potential weakness is the “crazy bullishness on gold” among the right-wing pundits like Ron Paul who have a long-standing affinity for the medal.

“They’re all on the bandwagon because of the rally in gold,” he says.

As with gold, he expects a similar seasonal pattern in other precious metals and copper. They will be weak from now through the end of the year, with a possible bounce in the middle of October.

“I’m wildly bullish over next six months,” says Williams.

He bases this call on where the dollar is in a 60- to 70-day cycle that tends to play out over time. It’s now coming off the recent lows in early September. He also cites readings from the Commitment of Traders Report showing that “smart money” commercial buyers are getting long the dollar, which is unusual.

“There’s a pretty good rally coming in the dollar,” he says.

Here are some stock patterns that should play out over the next several months, according to Williams’ system.

If you are psyched about Williams, here’s some bad news. He plans to close his trading site at the end of the year to focus more on personal trading.

“It’s a labor of love. It’s time to leave,” says Williams, who turns 78 in October.

I’ll stay in touch with him, and hopefully report to you on his market and trading views from time to time.

Michael Brush is a columnist for MarketWatch. At the time of publication, he owned CLR and CRK. Brush has suggested AMZN, IBM, WMT, TGT, HD, TIF, CLR and CRK in his stock newsletter, Brush Up on Stocks. Follow him on Twitter @mbrushstocks.

Source: www.marketwatch.com

Author: Michael Brush


Jim Cramer reacts to Unity stock market debut: 'Patience is a virtue'


Leave a Comment